Search by Blog
Read by Category

Your healing journey continues beyond this blog

Find the right products for better recovery at online store
Cart Image
US Patents Granted – Datt Mediproducts Pvt Ltd

“A patent is an intellectual property right which provides it’s owner right to exclude others from making, using, selling, and importing an invention for a limited period of time, usually twenty years, without authorization.”

The Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement between the member nations of the World Trade Organization (WTO) specifies the protection and enforcement procedures for all the intellectual property rights including Patents.

We @ Datt Mediproducts (DMP), are devoted to manufacturing & marketing of products of impeccable quality conforming to international standards. The Department of Life Sciences (DLS) is a research and development wing of Datt Mediproducts, recognized by the Department of Scientific and Industrial Research (DSIR), a unit of Government of India, with the state-of-the-art facility and well qualified and committed scientific staff working on the development of advanced wound care management.

DMP applied for 17 patents worldwide. Read further to know more about the patents which have been granted in the US.

US Patent No.: US 10,124,084 B2
Date of the Patent Granted: Nov. 13, 2018
Title of the Patent: A READY TO USE BIODEGRADABLE AND BIOCOMPATIBLE DEVICE AND A METHOD OF PREPARATION THEREOF

Brand: VELSEAL
The patent is granted for both the product as well as the process of its manufacturing. The invention is a ready to use the biodegradable and biocompatible device with high porosity, used to stop bleeding within a couple of minutes. The scaffold of the present invention comprises of a combined application of air dry and freeze dry method. The invention has excellent ventilation properties and can easily be removed from the wound without causing any extra hemorrhage.


US Patent No.:
US 10,076,552 B2
Date of the Patent Granted: Sep. 18, 2018
Title of the Patent: MULTIFUNCTIONAL FORMULATION COMPRISED OF NATURAL INGREDIENTS AND METHOD OF PREPARATION / MANUFACTURING THEREOF

Brand: VELVERT
The second patent is for a multifunctional formulation made from natural ingredients and the process to manufacture the same. This pharmaceutical preparation consists of the water-solubilized nano-sized formulation of a non-aqueous solvent extract of phytopharmaceuticals in herbal, animal or synthetic biocompatible gel or on matrix coated or both. This device is useful for the treatment of compromised tissue such as skin wounds and ulcers in humans and animals. It also relates to the anti-cancer transdermal patch for melanoma therapy and for the treatment of Alzheimer’s and multiple sclerosis also.


US Patent No.:
US 10,004,830 B2
Date of the Patent Granted: Jun. 26, 2018
&
US Patent No.: US 10,098,986 B1
Date of the Patent Granted: Oct. 16, 2018
&
US Patent No.: US 10,149,924 B1
Date of the Patent Granted: Dec. 1, 2018
Title of the Patent: READY TO USE BIODEGRADABLE AND BIOCOMPATIBLE ARTIFICIAL SKIN SUBSTITUTE AND A METHOD OF PREPARATION THEREOF

Brand: VELGRAFT
The third invention is for the brand VELGRAFT for which three US patents have been granted. It relates to a three-dimensional cell culture system which can be used to culture a variety of different cells (Human mesenchymal stem cells, Human fibroblast, Keratinocytes, fibroblast differentiated from mesenchymal stem cells in vitro and keratinocytes differentiated from mesenchymal stem cells in vitro) in vitro for continued periods of time.

This describes an invention in which mesenchymal stem cells (MSCs) derived  are inoculated and grown on a pre-established scaffold or matrix made up of chitosan and gelatin. The developed tissue constructs contain cells, growth factors, cytokines and other regulatory factors secreted by cells and provide the support, growth factors and essential cytokines for wound healing.

This invention is useful in the treatment of non-infected burn wounds, diabetic foot ulcers, venous leg ulcers and other types of chronic skin wounds. It’s helpful in the healing and regeneration of skin tissue.

 US Patent No.: US 15/081,202
Date of Patent Granted: January 2019
Title of the Patent: Ready to Use, Hydrophilic, Self-dispersive, Fragmentable, and Biodegradable Porous Sponge Matrix and a Method of Manufacturing Thereof

Brand: VELNEZ
The 6th patent is for the invention related to a porous absorbent Composite Material, which may be used e.g. in the form of a plug or tampon, for instance for packing antrum or other cavities of the body. As it is a hydrophilic Self-Dispersive, fragmentable and Bio-Absorbable Porous Composite foam it is helpful in controlling bleeding, wound closure, prevents tissue adhesion and/or support tissue regeneration.

Visit our website @ www.dattmedi.com

Visit www.dattmedi.com for more infomation.
Share:
Recent Blogs

In the realm of wound care, continuous advancements are constantly improving the way we treat and manage various types of wounds. Among the latest innovations, Velseal® -T Disc has emerged as a game-changer. This revolutionary product offers an effective and convenient solution for promoting wound healing and enhancing patient comfort.

Understanding Velseal® -T Disc

It is a cutting-edge wound care product designed to optimize the healing process while minimizing discomfort for patients. Velseal® -T Disc promotes haemostasis by absorbing the blood and accumulates clotting factor within the voids and initiate the clotting by interaction with Thrombin, Calcium chloride and Tranexamic acid.

Key Features and Benefits:

1. Advanced Composition:

It is composed of high-quality materials that offer excellent absorption and retention capacities, reducing the risk of maceration and infection. However, it does not provide moisture balance or directly contribute to wound healing.

2. Easy Application:

Thee disc-shaped design of Velseal® -T Disc allows for simple and hassle-free application. Its non-adherent nature eliminates the need for additional fixation methods, providing a secure and comfortable fit. The dressing is available in various sizes to accommodate different wound types and locations.

3. Enhanced Patient Comfort:

It prioritizes patient comfort by minimizing pain and trauma during dressing changes. The non-adherent surface prevents the dressing from sticking to the wound bed, reducing discomfort and potential damage to healing tissue.

4. Cost-Effective Solution:

It offers a cost-effective wound care solution, as it requires no dressing changes. A single application helps in achieving complete hemostasis, contributing to overall healthcare cost savings. Its durability and prolonged wear time further enhance its cost-effectiveness.

Clinical Efficacy and Evidence

The product has undergone rigorous testing and evaluation to validate its clinical efficacy. Clinical studies have demonstrated its effectiveness in promoting faster wound healing, reducing pain, and minimizing complications such as infection. These studies highlight the dressing’s superior moisture management capabilities and its ability to facilitate granulation tissue formation, resulting in improved patient outcomes.

In the rapidly evolving field of wound care, the Velseal® -T Disc stands out as a remarkable innovation. Its unique composition, easy application, and patient-centric design make it a valuable addition to any healthcare setting. With its demonstrated clinical efficacy and cost-effectiveness, this advanced dressing offers a promising solution for healthcare professionals and patients alike. By leveraging the benefits of Velseal® -T Disc, healthcare providers can enhance wound healing outcomes and improve the overall quality of care for patients with acute or chronic wounds.

In our fast-paced and demanding modern world, it has become increasingly crucial to prioritize our health and well-being. Among the myriad of health concerns affecting millions worldwide, cancer stands as one of the most significant challenges we face. However, with advances in medical science, early detection has emerged as a powerful tool in the fight against this devastating disease. In this blog, we will explore the importance of early cancer detection, shed light on screening guidelines, and emphasize the necessity of regular screenings for various types of cancer.

The Impact of Early Cancer Detection: Early detection plays a pivotal role in improving cancer outcomes and significantly increasing the chances of successful treatment. When cancer is detected in its early stages, before it has metastasized, treatment options are often less aggressive and more effective. Moreover, early detection significantly enhances survival rates, underscoring the vital importance of regular screenings for individuals.

Screening Guidelines for Different Types of Cancer:

Breast Cancer:

Among women, breast cancer is one of the most prevalent forms of the disease. The American Cancer Society advises that women aged 40 and above should undergo annual mammograms for breast cancer screening. However, individual risk factors may warrant earlier screenings or additional tests.


Colorectal Cancer:

Affecting both men and women, colorectal cancer ranks as the third most common cancer globally. Screening for colorectal cancer typically begins at the age of 45. Methods such as colonoscopy, sigmoidoscopy, and stool-based tests are employed to detect abnormal growths or cancerous cells in the colon or rectum.

Cervical Cancer:

Regular screenings and human papillomavirus (HPV) vaccination can prevent cervical cancer. The American Cancer Society recommends cervical cancer screening for individuals with a cervix starting at the age of 25. This can be achieved through a Pap test, an HPV test, or a combination of both.

Lung Cancer:

As the leading cause of cancer-related deaths worldwide, lung cancer poses a significant threat. For individuals at high risk, such as current or former smokers, low-dose computed tomography (LDCT) scans are recommended. Screening should commence at the age of 50 and continue until age 80, or as long as the individual is in good health.


Prostate Cancer:

Primarily affecting men, prostate cancer typically develops in older individuals. The American Cancer Society advises men to discuss the potential benefits and risks of prostate cancer screening with their healthcare provider. Screening options include prostate-specific antigen (PSA) blood tests and digital rectal exams.

Early cancer detection can save lives by enabling more effective treatment options and improving survival rates. By adhering to the recommended screening guidelines for different types of cancer, individuals can take proactive steps towards their health and potentially detect cancer in its early stages.

Through raising awareness, educating the public, and advocating for regular screenings, we can work together to alleviate the burden of cancer and enhance overall healthcare outcomes. Remember, prevention and early detection are the keys to triumphing over cancer. This strategic stance promises extended lives, improved outcomes, and a brighter future for all, underscoring the vital role of early cancer detection as a beacon of hope in a world where health is paramount.

×